IgA Nephropathy

>

The HCPLive Berger disease page is a resource for medical news and expert insights on IgA nephropathy. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments in Berger disease, and more.

Latest News

Joshua Salomon, PhD | Credit: Stanford University
Population-Wide CKD Screening Cost-Effective When Started At Age 55 Years, Study Finds

November 13th 2024

Initiation of population-wide CKD screening followed by conventional CKD treatment plus SGLT2 inhibitors at 55 years of age was cost-effective.

Hiddo Heerspink, PhD, PharmD | Credit: George Clinical
Phase 2 Data Highlight SC0062’s Dose-Dependent Impact on Proteinuria in IgA Nephropathy

November 11th 2024

John Sim, MD | Credit: Kaiser Permanente
Racial, Ethnic IgA Nephropathy Stratification Provides New Insight Into US Incidence

November 7th 2024

HCPLive Nephrology Month in Review: October 2024
Nephrology Month in Review: October 2024

November 6th 2024

 Jonathan Barratt, MBChB, PhD, Mayer Professor of Renal Medicine, University of Leicester, Leicester, United Kingdom
Felzartamab Slows IgAN Decline in New Phase 2 Data

October 30th 2024

© 2024 MJH Life Sciences

All rights reserved.